India’s healthcare global capability centres are evolving beyond support functions, according to an October analysis by Zinnov. The advisory firm argues that healthcare GCCs are increasingly trusted with operational decisions and complex cross-functional responsibilities. Its examples span life sciences, providers, payers and other healthcare sectors, and it notes that their progress is uneven because regulation and legacy systems make healthcare different from conventional IT services.
That distinction is important for India’s revenue-cycle industry. A hospital system might build a captive capability centre, buy services from an external RCM provider, or combine the two. The competitive boundary is less about geography than about who owns the workflow, the data, the technology and the measurable result.
From transaction support to ownership
Traditional outsourcing arrangements often start with a narrowly defined task: code a chart, verify coverage, post cash or contact a payer. A GCC can begin similarly but may eventually assume accountability for analytics, engineering, compliance coordination or broader process management. Moving up the value chain requires a different governance model because the team is no longer only completing assigned units of work; it is helping decide how the operation should function.
Zinnov highlights this shift with examples of healthcare operations expanding into multiple functions. The analysis should not be read as proof that all healthcare GCCs perform revenue-cycle management or that captive operations invariably outperform vendors. It is evidence of a direction of travel in the wider healthcare sector.
The choice facing U.S. healthcare buyers
A captive India centre offers direct control over staffing, intellectual property and technology decisions. But it also creates a management burden: recruiting leaders, operating infrastructure, maintaining information security and building resilient processes. Outsourcing can offer specialised expertise and faster access to capacity, but a buyer may have less immediate control over how the work evolves. Hybrid arrangements seek to combine direct strategic ownership with specialised delivery partners.
For a hospital CFO, the correct economic comparison is not salary versus invoice rate. It includes transition cost, retained management, systems integration, governance, process ownership, quality, cash performance and the ability to scale. A cheap arrangement that increases denials or delays collections can be more expensive in practice.
A sharper positioning challenge for Indian suppliers
If the customer’s own India centre can execute straightforward tasks, a third-party RCM vendor needs to explain its differentiated value. Some suppliers may be best at specialised coding, complex appeals or high-volume operational resilience. Others may bring payer intelligence, automated workflow tools or experience across many provider clients. Either model can work if its performance is measurable.
The more vulnerable pitch is a generic claim to provide large numbers of trained staff at a competitive rate. Healthcare customers increasingly need workflow improvement, not just labour arbitrage. Suppliers that share evidence on clean-claim rates, denial prevention, cost-to-collect and time-to-cash have a clearer basis for commercial discussions.
Talent and leadership are the constraint
The move toward operational ownership creates demand for experienced managers who understand U.S. revenue-cycle economics, security controls, process design and client accountability. A strong technical leader without payer-domain expertise may optimise the wrong measures; a strong operations leader without technology fluency may miss a chance to automate the right tasks.
Training programmes should therefore connect clinical coding and claims knowledge with data analysis, workflow design, risk management and communication. India’s depth of engineering talent is an advantage only when paired with healthcare-specific judgment and careful controls. GCCs and vendors will likely compete for many of the same leaders.
What buyers should track
The evidence to seek is not the number of jobs transferred to India but the decisions that Indian teams can own safely. Can the centre identify and correct denial root causes? Can it implement a payer-rule update without a costly chain of handoffs? Does it own a measurable improvement target? Is it authorised to change a workflow, and how is that change audited? These questions reveal whether a delivery location has become a centre of capability or remains a processing site.
Zinnov’s article is wider than RCM, and the implications here are analytical rather than direct predictions. Still, it supplies a timely framework for a central industry question: as India becomes home to more healthcare operating expertise, which work stays with external vendors, which moves inside GCCs and who captures the value created by automation?
Where a hybrid model can work
Consider a health system that retains its payer-contract strategy, enterprise data standards and clinical governance while partnering with an external specialist for complex appeals. Its India GCC might own analytics and technology development while the supplier handles defined operational exceptions. This arrangement can combine control with domain expertise, but only when data access, responsibility and performance standards are explicit.
The failure mode is unclear ownership. If the GCC and vendor each assume the other will update a payer edit or investigate a recurring denial, the result is a predictable backlog. Effective hybrids need a single accountable owner for every material process, shared reporting and an agreed pathway for changing the workflow. They also need a plan for when the vendor or captive team misses its service target.
What should not be inferred from sector growth
The presence of more healthcare GCCs does not automatically mean fewer outsourced RCM jobs. New captive centres may create demand for implementation partners, specialist services and experienced managers. Some providers may choose captive capabilities for strategic work and outsource high-volume execution; others may do the reverse. The balance will vary by organisation and specialty.
Likewise, broader healthcare GCC growth cannot be used as a precise forecast of RCM employment. Zinnov’s analysis covers life sciences and other healthcare functions as well as providers and payers. Any claim about RCM headcount or vendor revenue needs RCM-specific evidence. The useful insight is a structural shift in how healthcare expertise is organised in India, not a guaranteed winner between captive and outsourced models.